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Abstract
Introduction:  Adrenocortical carcinoma (ACC) is a rare malignancy with an estimated incidence of 1–2
per million people. It may recur, after complete surgical removal by local or distant metastasis.
Observation:  We report a case of late metastatic ACC presented as a mesenteric mass, 10 years post
left adrenalectomy. Our case was initially misdiagnosed radiologically as gastrointestinal stromal tumour
(GIST), and then the decision for exploration was made. The mass could be safely excised and confirmed
pathologically to be an adrenocortical tumour.
© 2016 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
m
p
p
s
pntroduction
drenal tumours are very common, affecting 3–10% of the human
opulation, and the majority are small benign nonfunctional adreno-
ortical adenoma [1]. Adrenocortical carcinoma (ACC) is a rare∗ Corresponding author.
-mail address: drahmedfali@gmail.com (A.F. Kotb).
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le [2]. There are 3 main clinical scenarios in which ACC patients
resent. For 40–60% of patients, the major presenting complaints are
ymptoms and signs of hormonal excess [3–5]. Another one-third
resent with non-specific symptoms due to local tumour growth,
uch as abdominal or flank pain, abdominal fullness, or early sati-
ty [4,5]. Roughly, 20–30% of ACCs are incidentally diagnosed
y imaging procedures for unrelated medical issues [6]. Patients
ith ACC only rarely present with classical tumour symptoms, such
s cachexia or night sweats while paraneoplastic syndromes are
ncommon [3,5].
and hosting by Elsevier B.V. This is an open access article under the CC
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In patients with localized ACC, operative resection remains the
mainstay of therapy. Patients with early-stage tumours who undergo
a complete resection have a 40% 5-year survival rate whereas those
with residual disease fare poorly [7]. Despite apparent complete
microscopic operative resection, ACC recurs either locally or with
distant metastasis in up to 50% of patients [7].
Gastrointestinal stromal tumours (GIST) present clinically with
vague abdominal pain, abdominal fullness or early satiety, resem-
bling one-third of cases suffering from ACC [8]. Radiologically,
GIST appear in CT as masses with soft tissue density, variable in size
and heterogeneity following contrast injection. In most of the cases,
it is located within the mesentery or directly related to the bowel
[8]. GIST resembles ACC in radiological appearance, except for
the location. Most of the tumours that were reported to be wrongly
diagnosed preoperatively as GIST were Schwannoma or Desmoid
tumours [9,10].
We describe this very rare clinical presentation of metastatic ACC
to the mesentery following previous two surgeries of left adrenal
gland for ACC followed by local tumour recurrence, radiologically
mimicking GIST.
Case  report
A 24-year-old female patient presented to our urology clinic with
vague upper abdominal discomfort. Her surgical history revealed
that in 2005 she underwent left adrenalectomy and the histopatho-
logical examination described a mass 12 cm ×  8 cm ×  5 cm of 130 g
in weight with microscopic features of tumour cells showing mild
nuclear atypia and rare mitotic figures, minimal necrosis and no vas-
cular invasion. The final pathologic diagnosis was left adrenocortical
neoplasm of indeterminate malignant potential.
Five years, post adrenalectomy, the patient complained of recurrent
attacks of left hypochondrial dull aching pain; when multiphasic CT
was done, it revealed a soft tissue mass lesion in the anatomical site
of left adrenal gland measuring 6 cm ×  7.2 cm ×  6.5 cm in dimen-
sion (Fig. 1). She underwent surgical exploration and excision of the
mass. Left nephrectomy was done due to accidental injury of left
renal vein during tumour resection. Histopathological examination
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Figure  2  CT image showing a recurrigure  1  CT image showing a recurrent large left suprarenal tumour.
evealed ACC with tumour-free surgical margin and the left kidney
as unremarkable.
urrently, she presented to our department with the same complaint
f generalized abdominal pain. Based on her history, we requested
ew multiphasic CT scan of abdomen and pelvis together with
ormonal workup.
ultiphasic CT scan revealed a 6 cm ovoid mass in the mesen-
ery (Fig. 2) to the left of inferior mesenteric vein with small
ndentation of related jejunal loop, as well as mesenteric sup-
ly and portal drainage suggestive of gastro-intestinal stromal
umour (GIST). Hormonal workup revealed normal ACTH level
<5 pg/ml), elevated serum cortisol level at 9 pm (20.3 g/dl) while
ormal level at 9 am (19.7 g/dl) and elevated urinary cortisol level
715 g/24 h urine of 1700 ml). All other hormonal workup was
ormal.
ltrasound-guides core biopsy was obtained from the
escribed mass and submitted for histopathological examina-
ion which described a metastatic oncocytic carcinoma. Further
mmune-histochemical staining to exclude carcinoid tumour
ent tumour within the mesentery.
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Figure  3  The insert shows the resected recurrent mass clearly identified intraoperatively, within the mesentery.
Figure  4  On scanning view, the tumour architecture was predominantly solid. Necrosis occupied a significant area of the tumour and had a
geographical pattern (H&E, 40×). On high power examination, the vast majority of the cells are polygonal with abundant eosinophilic cytoplasm, a
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Loderate degree of nuclear pleomorphism, prominent nucleoli, and ves
s well as occasional bizarre nuclei (arrow head). (Left) Low power im
evealed negative for chromogranin with Ki67 labels about 10% of
he nuclei.
urgical exploration was done through a small midline laparotomy
nd the mass was easily identified within the mesentery (Fig. 3).
otal excision was done. Post-operative course was smooth and the
ntraperitoneal drain was removed after 1 day.
istopathological examination of the excised mass described a
.5 cm ×  6 cm ×  3.5 cm grossly encapsulated mass with micro-
copic features of a tumour composed of solid sheets of eosinophilic
ells with vesicular moderately pleomorphic nuclei and wide areas
f necrosis. Final diagnosis was metastatic ACC (Fig. 4).
iscussione report a rare case of late metastatic ACC to the mesentery about
0 years following left adrenalectomy. Although the radiological
eatures of the mass together with the biopsy results were strongly
uggestive of GIST, the final pathology of the excised mass was
r
T
e
sr chromatin pattern. Atypical mitotic figures were also present (arrow)
nd (right) high power image.
etastatic ACC. We used Ki67 staining that was positive for 10%
f nuclei. It triggered us to proceed for exploration for its high
ssociation with malignancy and shorter disease specific survival
11].
ur case presented with a tumour recurrence in an abnormal
ocation, 10 years following initial radical surgery. Apart from
bdominal discomfort, she had a great performance status with no
ajor symptoms or signs of advanced malignancy. In a retrospec-
ive analysis from the German ACC registry, out of 154 patients
resented with recurrence following initial radical resection, 101
nderwent re-surgery. The best predictors of prolonged survival
fter first recurrence were time to first recurrence over 12 months
nd radical resection [12].
ocal recurrence and/or metastases are common after initial radical
esection for adrenal tumour, reaching up to 50% of cases [13,7].
hese cases have a low 5-year survival rate of 0–6% [13,7]. Hermsen
t al. [14] described 6 cases of late recurrence with excellent long
urvival. Our case presented with local recurrence 5 years following
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study group. World J Surg 2001;25:891–7.Recurrent ACC presenting as GIST 
initial radical resection, then 5 years later with a single metastasis
within the mesentery, associated with great performance status.
Our case is currently followed for 6 months following the third
surgery, with no clinical and radiological evidence of recurrence.
Conclusion
Adrenocortical carcinoma may present with late metastasis in an
abnormal location including the mesentery. Any mass suspected to
be gastrointestinal stromal tumour, in the presence of past history
of ACC should be investigated thoroughly by CT, core biopsy and
immunohistochemical staining.
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